SightfileU.S. market data from official filings
Companies › EXEL
EXELIXIS INC (EXEL)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0000939767 · EDGAR filings · Updated 2026-06-03
EXELIXIS INC (EXEL) has reported institutional ownership of 102.4%, with 692 institutional managers holding positions valued at $11.0B per the latest 13F reporting period.
Institutional ownership
102.4%
Institutional managers
692
Reported 13F value
$11.0B
Insider activity
103 trans.
−$50.9M net selling
Latest updates
- 2026-06-03 — Insider transaction reported (Form 4)
- 2026-06-03 — Insider transaction reported (Form 4)
- 2026-06-01 — Notice of proposed sale filed (Form 144)
- 2026-06-01 — Notice of proposed sale filed (Form 144)
- 2026-05-29 — Insider transaction reported (Form 4)
- 2026-05-29 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, EXELIXIS INC has 692 institutional holders and institutional ownership of 102.4%.
Insider activity
Insiders reported 103 transactions (1 buys, 37 sells) across 17 reporting insiders, with a net reported value of −$50.9M.
Related companies
ALIGN TECHNOLOGY INC (ALGN) · MEDPACE HLDGS INC (MEDP) · PENUMBRA INC (PEN) · ENSIGN GROUP INC (ENSG) · BIOMARIN PHARMACEUTICAL INC (BMRN) · BEONE MEDICINES LTD (ONC)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-03.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-03.